These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25959414)

  • 1. The epigenetically active small chemical N-methyl pyrrolidone (NMP) prevents estrogen depletion induced osteoporosis.
    Gjoksi B; Ghayor C; Siegenthaler B; Ruangsawasdi N; Zenobi-Wong M; Weber FE
    Bone; 2015 Sep; 78():114-21. PubMed ID: 25959414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
    Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
    J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of N-methyl pyrrolidone on the activity of the pulp-dentine complex and bone integrity during osteoporosis.
    Gjoksi B; Ruangsawasdi N; Ghayor C; Siegenthaler B; Zenobi-Wong M; Weber FE
    Int Endod J; 2017 Mar; 50(3):271-280. PubMed ID: 26913571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiosteoporotic activity of echinacoside in ovariectomized rats.
    Li F; Yang X; Yang Y; Guo C; Zhang C; Yang Z; Li P
    Phytomedicine; 2013 Apr; 20(6):549-57. PubMed ID: 23428402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bone regenerative effects of fucosterol in in vitro and in vivo models of postmenopausal osteoporosis.
    Lee DG; Park SY; Chung WS; Park JH; Shin HS; Hwang E; Kim IH; Yi TH
    Mol Nutr Food Res; 2014 Jun; 58(6):1249-57. PubMed ID: 24604889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
    Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
    Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-osteoporosis activity of Cibotium barometz extract on ovariectomy-induced bone loss in rats.
    Zhao X; Wu ZX; Zhang Y; Yan YB; He Q; Cao PC; Lei W
    J Ethnopharmacol; 2011 Oct; 137(3):1083-8. PubMed ID: 21782010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats.
    Peng S; Zhang G; Zhang BT; Guo B; He Y; Bakker AJ; Pan X; Zhen W; Hung L; Qin L; Leung WN
    Bone; 2013 Jul; 55(1):230-40. PubMed ID: 23486180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiosteoporotic activity of Saururus chinensis extract in ovariectomized rats.
    Sung MJ; Davaatseren M; Hur HJ; Kim HJ; Ryu SY; Choi YH; Cha MR; Kwon DY
    Phytother Res; 2012 Aug; 26(8):1182-8. PubMed ID: 22821855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen Deficiency-Associated Bone Loss in the Maxilla: A Methodology to Quantify the Changes in the Maxillary Intra-radicular Alveolar Bone in an Ovariectomized Rat Osteoporosis Model.
    Du Z; Steck R; Doan N; Woodruff MA; Ivanovski S; Xiao Y
    Tissue Eng Part C Methods; 2015 May; 21(5):458-66. PubMed ID: 25315176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-osteoporotic effect of Yijung-tang in an ovariectomized rat model mediated by inhibition of osteoclast differentiation.
    Kim T; Ha H; Shim KS; Cho WK; Ma JY
    J Ethnopharmacol; 2013 Mar; 146(1):83-9. PubMed ID: 23219731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats.
    Fanti P; Monier-Faugere MC; Geng Z; Schmidt J; Morris PE; Cohen D; Malluche HH
    Osteoporos Int; 1998; 8(3):274-81. PubMed ID: 9797913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tob deficiency superenhances osteoblastic activity after ovariectomy to block estrogen deficiency-induced osteoporosis.
    Usui M; Yoshida Y; Tsuji K; Oikawa K; Miyazono K; Ishikawa I; Yamamoto T; Nifuji A; Noda M
    Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6653-8. PubMed ID: 15100414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiosteoporotic activity of Davallia formosana.
    Ko YJ; Wu JB; Ho HY; Lin WC
    J Ethnopharmacol; 2012 Jan; 139(2):558-65. PubMed ID: 22155390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of egg yolk peptide on bone metabolism.
    Kim HK; Lee S; Leem KH
    Menopause; 2011 Mar; 18(3):307-13. PubMed ID: 21107301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats.
    Xu D; Yang W; Zhou C; Liu Y; Xu B
    Planta Med; 2010 Nov; 76(16):1809-13. PubMed ID: 20577944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats.
    Marie PJ; Hott M; Modrowski D; De Pollak C; Guillemain J; Deloffre P; Tsouderos Y
    J Bone Miner Res; 1993 May; 8(5):607-15. PubMed ID: 8511988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
    Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
    J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.